Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
The DOI matches its Crossref record; 380 of the 380 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–380 of 380
Fukumoto, H., Deng, A., Irizarry, M. C., Fitzgerald, M. L., & Rebeck, G. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209085200 · Cited by 160
A new multidrug resistance protein at the blood–brain barrier
Eisenblaetter, T., & Galla, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00376-5 · Cited by 160
Importance of P‐glycoprotein for drug disposition in humans
Fromm, M. F. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.4.x · Cited by 158
Decl�ves, X., Regina, A., Laplanche, J.-L., Roux, F., Boval, B., Launay, J.-M., & Scherrmann, J.-M. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000601)60:5<594::aid-jnr4>3.0.co;2-6 · Cited by 158
A Pharmacophore for Human Pregnane X Receptor Ligands
Ekins, S., & Erickson, J. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.1.96 · Cited by 155
The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders
Taylor, E. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241020-00001 · Cited by 153
Gennuso, F., Fernetti, C., Tirolo, C., Testa, N., L'Episcopo, F., Caniglia, S., Morale, M. C., Ostrow, J. D., Pascolo, L., Tiribelli, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308452100 · Cited by 152
Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin
Fabel, K., Dietrich, J., Hau, P., Wismeth, C., Winner, B., Przywara, S., Steinbrecher, A., Ullrich, W., & Bogdahn, U. (2001) · Cancer · doi:10.1002/1097-0142(20011001)92:7<1936::aid-cncr1712>3.0.co;2-h · Cited by 151
P‐glycoprotein is localized in caveolae in resistant cells and in brain capillaries
Demeule, M., Jodoin, J., Gingras, D., & Béliveau, R. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01087-5 · Cited by 150
Hori, S., Ohtsuki, S., Tachikawa, M., Kimura, N., Kondo, T., Watanabe, M., Nakashima, E., & Terasaki, T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02537.x · Cited by 150
Seelig, A., Li‐Blatter, X., & Wohnsland, F. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38111 · Cited by 148
Graff, C. L., & Pollack, G. M. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489126 · Cited by 147
Carbamazepine is not a substrate for P‐glycoprotein
Owen, A., Pirmohamed, M., Tettey, J. N. A., Morgan, P., Chadwick, D. W., & Park, B. K. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01359.x · Cited by 146
Significance of MDR1 and multiple drug resistance in refractory human epileptic brain
Marchi, N., Hallene, K. L., Kight, K. M., Cucullo, L., Moddel, G., Bingaman, W., Dini, G., Vezzani, A., & Janigro, D. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-37 · Cited by 146
Brain Microvascular and Astrocyte Localization of P‐Glycoprotein
Pardridge, W. M., Golden, P. L., Kang, Y., & Bickel, U. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031278.x · Cited by 144
Asaba, H., Hosoya, K., Takanaga, H., Ohtsuki, S., Tamura, E., Takizawa, T., & Terasaki, T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751907.x · Cited by 144
Regulation of the multidrug resistance genes by stress signals.
Sukhai, M. A., & Piquette‐Miller, M. (2000) · PubMed · Cited by 143
Dro??dzik, M., Bia??ecka, M., My??liwiec, K., Honczarenko, K., Stankiewicz, J., & Sych, Z. (2003) · Pharmacogenetics · doi:10.1097/00008571-200305000-00004 · Cited by 143
Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
Lockhart, A. C., Tirona, R. G., & Kim, R. B. (2003) · PubMed · Cited by 141
P-Glycoprotein Mediates the Efflux of Quinidine across the Blood-Brain Barrier
Kusuhara, H., Suzuki, H., Terasaki, T., Kakee, A., Lemaire, M., & Sugiyama, Y. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37075-2 · Cited by 141
Effects of Lipids on ATPase Activity of Purified Chinese Hamster P-Glycoprotein
Urbatsch, I. L., & Senior, A. E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1020 · Cited by 140
Lee, Y. J., Kusuhara, H., Jonker, J. W., Schinkel, A. H., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073320 · Cited by 140
The Human ATP-Binding Cassette Transporter Genes From the Bench to the Bedside
Efferth, T. (2001) · Current Molecular Medicine · doi:10.2174/1566524013364194 · Cited by 139
Saito, S., Iida, A., Sekine, A., Miura, Y., Ogawa, C., Kawauchi, S., Higuchi, S., & Nakamura, Y. (2002) · Journal of Human Genetics · doi:10.1007/s100380200018 · Cited by 135
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse, N. H., de Vries, E. G. E., Eriks-Fluks, L., van der Graaf, W. T. A., Hospers, G. A. P., Willemsen, A. T. M., Vaalburg, W., & Franssen, E. J. F. (1999) · PubMed · Cited by 135
An Overview of In Vitro Techniques for Blood-Brain Barrier Studies
Reichel, A., Begley, D. J., & Abbott, N. J. (2003) · Blood-Brain Barrier, · doi:10.1385/1-59259-419-0:307 · Cited by 134
Ohnishi, T., Tamai, I., Sakanaka, K., Sakata, A., Yamashima, T., Yamashita, J., & Tsuji, A. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00082-b · Cited by 132
Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays
Lohmann, C., Hüwel, S., & Galla, H. (2002) · Journal of drug targeting · doi:10.1080/10611860290031903 · Cited by 132
Hirrlinger, J., König, J., & Dringen, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01082.x · Cited by 131
Introduction to the blood-brain barrier : methodology, biology, and pathology
Pardridge, W. M. (2006) · Medical Entomology and Zoology · Cited by 130
Soranzo, N., Gl, C., Weale, M. E., Wood, N. W., Depondt, C., Marguerie, R., Sisodiya, S. M., & Goldstein, D. B. (2004) · Genome Research · doi:10.1101/gr.1965304 · Cited by 129
Epilepsy and the blood-brain barrier.
Cornford, E. M., & Oldendorf, W. H. (1986) · PubMed · Cited by 128
Gaillard, P. J., van der Sandt, I. C. J., Voorwinden, L. H., Vu, D., Nielsen, J. L., de Boer, A. G., & Breimer, D. D. (2000) · Pharmaceutical Research · doi:10.1023/a:1026406528530 · Cited by 128
Lee, G. S., & Bendayan, R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036905.82914.8e · Cited by 128
Katzov, H., Chalmers, K., Palmgren, J., Andreasen, N., Johansson, B., Cairns, N. J., Gatz, M., Wilcock, G. K., Love, S., Pedersen, N. L., et al. (2004) · Human Mutation · doi:10.1002/humu.20012 · Cited by 127
By-passing of P-glycoprotein Using Immunoliposomes
Huwyler, J., Cerletti, A., Fricker, G., Eberle, A. N., & Drewe, J. (2002) · Journal of Drug Targeting · doi:10.1080/10611860290007559 · Cited by 126
Uhr, M., & Grauer, M. T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00022-0 · Cited by 126
Löscher, W., & Rundfeldt, C. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20238-5 · Cited by 126
Self-citationVolk, H. A., Burkhardt, K., Potschka, H., Chen, J., Becker, A., & Löscher, W. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.012 · Cited by 125
Self-citationVolk, E. L., Rohde, K., Rhee, M., McGuire, J. J., Doyle, L. A., Ross, D. D., & Schneider, E. (2000) · PubMed · Cited by 125
Pharmacogenomics of the OATP and OAT Families
Marzolini, C., Tirona, R. G., & Kim, R. B. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.3.273.29831 · Cited by 124
Glial cells express multiple ATP binding cassette proteins which are involved in ATP release
Ballerini, P., Iorio, P. D., Ciccarelli, R., Nargi, E., D’Alimonte, I., Traversa, U., Rathbone, M. P., & Caciagli, F. (2002) · Neuroreport · doi:10.1097/00001756-200210070-00019 · Cited by 124
Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
Sun, J., He, Z.-G., Cheng, G., Wang, S., Hao, X.-H., & Zou, M. (2004) · PubMed · Cited by 123
Felix, R. A., & Barrand, M. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00660.x · Cited by 123
Multidrug-Resistance Transporters
Silverman, J. A. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-46812-3_13 · Cited by 123
Kim, H., Barroso, M., Samanta, R., Greenberger, L., & Sztul, E. (1997) · American Journal of Physiology · doi:10.1152/ajpcell.1997.273.2.c687 · Cited by 122
Doxorubicin-peptide conjugates overcome multidrug resistance
Mazel, M., Clair, P., Rousselle, C., Vidal, P., Scherrmann, J., Mathieu-Mahul, D., & Temsamani, J. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200102000-00003 · Cited by 122
Bourasset, F., Cisternino, S., Temsamani, J., & Scherrmann, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01990.x · Cited by 122
van der Sandt, I. C. J., Vos, C. M. P., Nabulsi, L., Blom-Roosemalen, M. C. M., Voorwinden, H. H., de Boer, A. G., & Breimer, D. D. (2001) · AIDS · doi:10.1097/00002030-200103090-00007 · Cited by 118
Increased brain P-glycoprotein in morphine tolerant rats
Aquilante, C. L., Letrent, S. P., Pollack, G. M., & Brouwer, K. L. R. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00599-8 · Cited by 117
ABC transporters and inhibitors: new targets, new agents.
Leonard, G. D., Polgár, O., & Bates, S. E. (2002) · PubMed · Cited by 115
Luurtsema, G., Molthoff, C. F. M., Windhorst, A. D., Smit, J. W., Keizer, H. G., Boellaard, R., Lammertsma, A. A., & Franssen, E. J. F. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(03)00078-7 · Cited by 115
Over-expression of Pglycoprotein in malformations of cortical development
Sisodiya, S. M., Heffernan, J. M., & Squier, M. V. (1999) · Neuroreport · doi:10.1097/00001756-199911080-00032 · Cited by 115
Brain Perfusion Systems for Studies of Drug Uptake and Metabolism in the Central Nervous System
Smith, Q. R. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5_15 · Cited by 114
Seegers, U., Potschka, H., & Löscher, W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00156-0 · Cited by 114
Self-citationP-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice
Sills, G. J., Kwan, P., Butler, E., de Lange, E. C. M., van den Berg, D., & Brodie, M. J. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00511-5 · Cited by 113
Megard, I., Garrigues, A., Orlowski, S., Jorajuria, S., Clayette, P., Ezan, É., & Mabondzo, A. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03337-6 · Cited by 112
Meaden, E. R. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf161 · Cited by 110
The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone
Karssen, A., Meijer, O., van der Sandt, I., De Boer, A., De Lange, E., & De Kloet, E. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750251 · Cited by 110
Drug Resistance in Epilepsy: The Role of the Blood–Brain Barrier
Abbott, N. J., Khan, E. U., Rollinson, C. M. S., Reichel, A., Janigro, D., Dombrowski, S. M., Dobbie, M. S., & Begley, D. J. (2002) · Novartis Foundation Symposia · doi:10.1002/0470846356.ch4 · Cited by 109
A Role for P-Glycoprotein in Regulating Cell Death
Johnstone, R. W., Ruefli, A. A., Tainton, K. M., & Smyth, M. J. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009060314 · Cited by 109
Volk, H., Potschka, H., & Löscher, W. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6451.2005 · Cited by 109
Self-citationJodoin, J., Demeule, M., Fenart, L., Cecchelli, R., Farmer, S., Linton, K. J., Higgins, C. F., & Béliveau, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02081.x · Cited by 108
Modulation of Drug Transporters at the Blood-Brain Barrier
Fricker, G., & Miller, D. S. (2004) · Pharmacology · doi:10.1159/000075545 · Cited by 107
Zhu, H., & Liu, G.-Q. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.02.027 · Cited by 106
Praul, C. A., Brubaker, K. D., Leach, R. M., & Gay, C. V. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8757 · Cited by 105
Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.
Elsinga, P. H., Franssen, E. J. F., Hendrikse, N. H., Eriks-Fluks, L., Weemaes, A.-M. A., van der Graaf, W. T., de Vries, E. G. E., Visser, G. M., & Vaalburg, W. (1996) · PubMed · Cited by 105
Endocytosis and Transcytosis of an Immunoliposome-Based Brain Drug Delivery System
Cerletti, A., Drewe, J., Fricker, G., Eberle, A., & Huwyler, J. (2000) · Journal of Drug Targeting · doi:10.3109/10611860008997919 · Cited by 105
Kusuhara, H., Suzuki, H., Naito, M., TSURUO, T., & Sugiyama, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37528-7 · Cited by 104
Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and Vinblastine
Drion, N., Lemaire, M., Lefauconnier, J. ‐., & Scherrmann, J. ‐. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041688.x · Cited by 104
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells
Letrent, S. P., Polli, J. W., Humphreys, J. E., Pollack, G. M., Brouwer, K. R., & Brouwer, K. L. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00180-x · Cited by 104
Potential New Methods for Antiepileptic Drug Delivery
Fisher, R. S., & Ho, J. (2002) · CNS Drugs · doi:10.2165/00023210-200216090-00001 · Cited by 103
Penetration of intra-arterially administered vincristine in experimental brain tumor
Boyle, F. M., Eller, S., & Grossman, S. A. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000516 · Cited by 102
Safety and Tolerability of Fluoroquinolones
Norrby, S. R., & Lietman, P. S. (1993) · Drugs · doi:10.2165/00003495-199300453-00012 · Cited by 101
Deng, L., Lin-Lee, Y.-C., Claret, F.-X., & Kuo, M. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004551200 · Cited by 101
Takasawa, K., Terasaki, T., Suzuki, H., & Sugiyama, Y. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36602-9 · Cited by 100
Potschka, H., Baltes, S., & Löscher, W. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.12.007 · Cited by 100
Self-citationDistribution of valproate across the interface between blood and cerebrospinal fluid
Frey, H. ‐., & Löscher, W. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90160-0 · Cited by 100
Self-citationSugiyama, D., Kusuhara, H., Lee, Y. J., & Sugiyama, Y. (2003) · Pharmaceutical Research · doi:10.1023/a:1025749925541 · Cited by 99
P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries
Golden, P. L., & Pardridge, W. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01305-5 · Cited by 98
Régina, A., Romero, I. A., Greenwood, J., Adamson, P., Bourre, J. M., Couraud, P., & Roux, F. S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.01954.x · Cited by 98
Blood—Brain—Cerebrospinal Fluid Barriers
Laterra, J., Keep, R. F., Betz, L. A., & Goldstein, G. W. (1999) · Cited by 98
Zhang, L., Ong, W.-Y., & Lee, T. (1999) · Experimental Brain Research · doi:10.1007/s002210050759 · Cited by 97
The mechanism of ATP-dependent multidrug transport by P-glycoprotein.
Shapiro, A. B., & Ling, V. W. T. (1998) · PubMed · Cited by 97
Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes
Mercier, C., Masseguin, C., Roux, F. S., Gabrion, J., & Scherrmann, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.034 · Cited by 96
Xenobiotic efflux pumps in isolated fish brain capillaries
Miller, D. S., Graeff, C., Droulle, L., et al. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00305.2001 · Cited by 95
Multidrug resistance of cancer cells
Kane, S. E. (1996) · Advances in Drug Research · doi:10.1016/s0065-2490(96)80005-0 · Cited by 95
Cell Degeneration Induced by Amyloid-β Peptides: Implications for Alzheimer's Disease
Pereira, C., Ferreiro, E. B., Cardoso, S. M., & Oliveira, C. R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:097 · Cited by 94
Anti-HIV Drug Distribution to the Central Nervous System
Thomas, S. A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384835 · Cited by 94
Brandt, C., Volk, H. A., & Löscher, W. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16904.x · Cited by 93
Self-citationPolli, J. W., Baughman, T. M., Humphreys, J. E., Jordan, K. H., Mote, A. L., Salisbury, J. A., Tippin, T. K., & Serabjit‐Singh, C. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10453 · Cited by 93
Organic anion transport across the choroid plexus
Gao, B., & Meier, P. J. (2000) · Microscopy Research and Technique · Cited by 90
Washington, C. B., WILTSHIRE, H. R., Man, M., Moy, T., Harris, S. R., Worth, E., Weigl, P., Liang, Z., Hall, D., Marriott, L., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15186-0 · Cited by 90
Altered P-Glycoprotein Expression in AIDS Patients with HIV Encephalitis
Langford, D., Grigorian, A., Hurford, R., Adame, A., Ellis, R. J., Hansen, L., & Masliah, E. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1038 · Cited by 89
Pallis, M., Turzanski, J., Higashi, Y., & Russell, N. H. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026277 · Cited by 89
Cellular localization and functional expression of P‐glycoprotein in rat astrocyte cultures
Ronaldson, P. T., Bendayan, M., Gingras, D., Piquette‐Miller, M., & Bendayan, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02417.x · Cited by 89
How significant is the role of P-glycoprotein in drug absorption and brain uptake?
Lin, J. H. (2004) · Drugs of today · doi:10.1358/dot.2004.40.1.799434 · Cited by 87
Müller, M. B., Keck, M. E., Binder, E. B., Kresse, A. E., Hagemeyer, T. P., Landgraf, R., Holsboer, F., & Uhr, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300257 · Cited by 86
Orphan Nuclear Receptor Modulators
Mohan, R., & Heyman, R. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451709 · Cited by 86
Cisternino, S., Rousselle, C., Dagenais, C., & Scherrmann, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011080418027 · Cited by 85
Drug-stimulated Nucleotide Trapping in the Human Multidrug Transporter MDR1
Szabó, K., Welker, E., Bakos, É., Müller, M., Roninson, I. B., Váradi, A., & Sarkadi, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10132 · Cited by 84
Fénart, L., Buée‐Scherrer, V., Descamps, L., Duhem, C., Poullain, M., Cecchelli, R., & Dehouck, M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011913723928 · Cited by 83
Tamai, I., Yamashita, J., Kido, Y., Ohnari, A., Sai, Y., Shima, Y., Naruhashi, K., Koizumi, S., & Tsuji, A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38880-9 · Cited by 83
Volk, H. A., Potschka, H., & Löscher, W. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.12.009 · Cited by 82
Self-citationBlood–brain barrier permeability to small and large molecules
Cornford, E. M., & Hyman, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00082-9 · Cited by 82
Major Vault Protein, a Marker of Drug Resistance, Is Upregulated in Refractory Epilepsy
Sisodiya, S. M., Martinian, L., Scheffer, G. L., van der Valk, P., Cross, J. H., Scheper, R. J., Harding, B. N., & Thom, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.21803.x · Cited by 81
Microdialysis for pharmacokinetic analysis of drug transport to the brain
de Lange, E. C. M., de Boer, B. G., & Breimer, D. D. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00089-1 · Cited by 81
Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Marroni, M., Marchi, N., Cucullo, L., Abbott, N., Signorelli, K., & Janigro, D. (2003) · Current Drug Targets · doi:10.2174/1389450033491109 · Cited by 81
Sonoda, J., Rosenfeld, J. M., Xu, L., Evans, R. M., & Xie, W. (2003) · Current Drug Metabolism · doi:10.2174/1389200033336739 · Cited by 81
Brain Microvascular P-Glycoprotein and a Revised Model of Multidrug Resistance in Brain
Golden, P. L., & Pardridge, W. M. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007093521681 · Cited by 79
Barrand, M. A., Robertson, K., & von Weikersthal, S. F. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01104-m · Cited by 79
Chishty, M., Reichel, A., Siva, J., Abbott, N. J., & Begley, D. J. (2001) · Journal of drug targeting · doi:10.3109/10611860108997930 · Cited by 77
Gutmann, H., Török, M., Fricker, G., Huwyler, J., Beglinger, C., & Drewe, J. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15245-2 · Cited by 77
Cisternino, S., Rousselle, C., Lorico, A., Rappa, G., & Scherrmann, J. (2003) · Pharmaceutical Research · doi:10.1023/a:1023895404929 · Cited by 76
Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein
Shirai, A., Naito, M., Tatsuta, T., Dong, J., Hanaoka, K., Mikami, K., Oh‐hara, T., & Tsuruo, T. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90047-7 · Cited by 76
Dagenais, C., Ducharme, J., & Pollack, G. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01640-8 · Cited by 75
Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats
Potschka, H., Volk, H. A., & Löscher, W. (2004) · Neuroreport · doi:10.1097/01.wnr.0000134840.10390.a4 · Cited by 75
Self-citationTreatment-resistant schizophrenia: reviewing the options and identifying the way forward.
Hellewell, J. S. E. (1999) · PubMed · Cited by 74
Tsai, T. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf020603p · Cited by 73
Nallani, S. C., Glauser, T. A., Hariparsad, N., Setchell, K., Buckley, D. J., Buckley, A. R., & Desai, P. B. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.06203.x · Cited by 73
VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts
Danielsen, T., & Rofstad, E. K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980610)76:6<857::aid-ijc15>3.0.co;2-# · Cited by 73
Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology
MNH, &. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00012 · Cited by 72
Potschka, H., & Löscher, W. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00020 · Cited by 71
Self-citationKitazawa, T., Hosoya, K., Watanabe, M., Takashima, T., Ohtsuki, S., Takanaga, H., Ueda, M., Yanai, N., Obinata, M., & Terasaki, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011014424212 · Cited by 70
Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport
Gibbs, J. P., Adeyeye, M. C., Yang, Z., & Shen, D. D. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.12.008 · Cited by 68
Gath, U., Hakvoort, A., Wegener, J., Decker, S. R. R., & Galla, H. (1997) · PubMed · Cited by 68
Effect of P‐glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis
Tsai, T., Lee, C. H., & Yeh, P.-H. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704363 · Cited by 65
Transport of Fluorescein in MDCKII-MRP1 Transfected Cells and mrp1-Knockout Mice
Sun, H., Johnson, D. R., Finch, R. A., Sartorelli, A. C., Miller, D. W., & Elmquist, W. F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5062 · Cited by 65
How does P-glycoprotein recognize its substrates?
Seelig, A. (1998) · PubMed · Cited by 64
In Situ Brain Perfusion Technique
Smith, Q. R., & Allen, D. D. (2003) · Blood-Brain Barrier, · doi:10.1385/1-59259-419-0:209 · Cited by 64
Takakura, Y., Audus, K. L., & Borchardt, R. T. (1991) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60034-4 · Cited by 63
Paschen, W., Oláh, L., & Mies, G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751675.x · Cited by 63
Potschka, H., Fedrowitz, M., & Löscher, W. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.22603.x · Cited by 63
Self-citationEdwards, J. E., Brouwer, K. R., & McNamara, P. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2284-2286.2002 · Cited by 63
Seegers, U., Potschka, H., & Löscher, W. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.33101.x · Cited by 62
Self-citationFunctional Characterization of Choroid Plexus Epithelial Cells in Primary Culture
Villalobos, A. R. A., Parmelee, J. T., & Pritchard, J. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36887-9 · Cited by 62
Active transport properties of porcine choroid plexus cells in culture
Hakvoort, A., Haselbach, M., & Galla, H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00284-4 · Cited by 61
Safety and tolerability of fluoroquinolones
Sprandel, K. A., & Rocivold, K. A. (2003) · Clinical cornerstone · doi:10.1016/s1098-3597(03)90027-5 · Cited by 60
Hendrikse, N. H., Kuipers, F., Meijer, C., Havinga, R., Bijleveld, C. M. A., van der Graaf, W. T. A., Vaalburg, W., & de Vries, E. G. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0793-2 · Cited by 60
P-glycoprotein and caveolin-1α in endothelium and astrocytes of primate brain
Schlachetzki, F., & Pardridge, W. M. (2003) · NeuroReport · doi:10.1097/00001756-200311140-00007 · Cited by 60
Sykes, D. B., Sweet, D. H., Lowes, S., Nigám, S. K., Pritchard, J. B., & Miller, D. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00356.2003 · Cited by 60
van Vliet, E. A., Aronica, E., Redeker, S., Marchi, N., Rizzi, M., Vezzani, A., & Gorter, J. A. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.06.005 · Cited by 59
Epilepsy and the blood brain barrier: endothelial cell responses to seizures.
Cornford, E. M. (1999) · PubMed · Cited by 58
Widespread Upregulation of Drug‐resistance Proteins in Fatal Human Status Epilepticus
Sisodiya, S. M., & Thom, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.42802.x · Cited by 57
Drug Transport in the Mammalian Central Nervous System: Multiple Complex Systems
Spector, R. (2000) · Pharmacology · doi:10.1159/000028349 · Cited by 57
Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression
Murck, H., Song, C., Horrobin, D. F., & Uhr, M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004249 · Cited by 57
Ohtsuki, S., Takizawa, T., Takanaga, H., Terasaki, N., Kitazawa, T., Sasaki, M., Abe, T., Hosoya, K., & Terasaki, T. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.532 · Cited by 57
Marroni, M., Agrawal, M., Kight, K. E., Hallene, K. L., Hossain, M. A., Cucullo, L., Signorelli, K. L., Namura, S., Bingaman, W. E., & Janigro, D. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00515-3 · Cited by 54
Awasthi, S., Singhal, S., Singhal, J., Yang, Y., Zimniak, P., & Awasthi, Y. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.721 · Cited by 54
Choroid Plexus Transporters for Drugs and Other Xenobiotics
Ghersi‐Egea, J., & Strazielle, N. (2002) · Journal of drug targeting · doi:10.1080/10611860290031859 · Cited by 53
Permeability of porcine blood brain barrier to somatostatin analogues
Fricker, G., Nobmann, S., & Miller, D. S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704557 · Cited by 53
Treatment options for status epilepticus
Lowenstein, D. H. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.003 · Cited by 53
Drug transporters in HIV Therapy.
Kim, R. B. (2003) · PubMed · Cited by 52
Goodwin, B. J., & Moore, J. T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.007 · Cited by 52
Adkison, K. D. K., Artru, A. A., Powers, K. M., & Shen, D. D. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39013-0 · Cited by 52
Ishikawa, T., Onishi, Y., Hirano, H., Oosumi, K., Nagakura, M., & Tarui, S. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.939 · Cited by 51
T�r�k, M., Huwyler, J., Gutmann, H., Fricker, G., & Drewe, J. (2003) · Experimental Brain Research · doi:10.1007/s00221-003-1620-4 · Cited by 50
Sasabe, H., Kato, Y., SUZUKI, T. A., Itose, M., Miyamoto, G., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065201 · Cited by 50
Scism-Bacon, J. L., Powers, K. M., Artru, A. A., Lewis, L., & Shen, D. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02893-6 · Cited by 48
In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance
M�ri�n, T., Szab�, G., Goda, K., Nagy, H., Szincs�k, N., Juh�sz, I., Galuska, L., Balkay, L., Mikecz, P., Tr�n, L., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1204-3 · Cited by 48
Clinical experience of marketed Levetiracetam in an epilepsy clinic—a one year follow up study
Betts, T., YARROW, H., Greenhill, L., & BARRETT, M. (2003) · Seizure · doi:10.1016/s1059-1311(02)00258-3 · Cited by 48
Shibayama, Y., Ikeda, R., Motoya, T., & Yamada, K. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.02.012 · Cited by 48
Drug delivery via the blood–brain barrier
Edwards, R. H. (2001) · Nature Neuroscience · doi:10.1038/85045 · Cited by 47
The blood-brain barrier : biology and research protocols
Nag, S. (2003) · Humana Press eBooks · Cited by 47
Grauer, M. T., & Uhr, M. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042831 · Cited by 43
Hypothalamic-Pituitary-Adrenocortical System and Mood Disorders: Highlights from Mutant Mice
Müller, M. B., Uhr, M., Holsboer, F., & Keck, M. E. (2004) · Neuroendocrinology · doi:10.1159/000076041 · Cited by 40
Differential expression of multidrug resistance genes in naıve rat brain
Kwan, P., Sills, G. J., Butler, E., Gant, T. W., & Brodie, M. J. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01453-2 · Cited by 35
Blood-Brain Barrier Penetration and Drug Development from an Industrial Point of View
Mertsch, K., & Maas, J. (2002) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1568015023358067 · Cited by 35
Chapter 18: Development of an in vitro cell culture system to mimic the blood-brain barrier
Rauh, J., Meyer, J., Beuckmann, C. T., & Galla, H. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)62325-0 · Cited by 35
Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats
Hosoya, K., Asaba, H., & Terasaki, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00861-4 · Cited by 34
Pippert, T. R., & Umbenhauer, D. R. (2001) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.3 · Cited by 32
Ibrahim, S., Peggins, J. O., Knapton, A. D., Licht, T., & Aszalos, A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39030-5 · Cited by 32
van der Sandt, I. C. J., Smolders, R., Nabulsi, L., Zuideveld, K. P., de Boer, A. G., & Breimer, D. D. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00150-6 · Cited by 31
Pallis, M., Turzanski, J., Grundy, M. A., Seedhouse, C., & Russell, N. H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04210.x · Cited by 29
Yamamoto, C., 村上, 秀., Koyabu, N., Takanaga, H., Matsuo, H., Uchiumi, T., Kuwano, M., Naito, M., Tsuruo, T., Ohtani, H., et al. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702320266208 · Cited by 28
Potentiation of domperidone‐induced catalepsy by a P‐glycoprotein inhibitor, cyclosporin A
Tsujikawa, K., Dan, Y., Nogawa, K., Sato, H., Yamada, Y., 村上, 秀., Ohtani, H., Sawada, Y., & Iga, T. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.343 · Cited by 27
Mechanisms of Drug Resistance in Epilepsy: Lessons from Oncology
Binder, D. K. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02441-8 · Cited by 25
Circulating neuroactive peptides and the blood-brain and blood-cerebrospinal fluid barriers.
Zloković, B. V., Mb, S., Davson, H., Lipovac, M. N., Hyman, S., & McComb, J. G. (1990) · PubMed · Cited by 25
Pendse, S. S., Sayegh, M. H., & Frank, M. H. (2003) · Current Drug Targets · doi:10.2174/1389450033490894 · Cited by 24
The blood–brain barrier. Biology and research protocols
Koeppen, A. H. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00265-x · Cited by 18
Cited by
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
“Drug efflux transporters, such as P-glycoprotein (Pgp), are mainly present on the luminal membrane surface (Loscher and Potschka 2005b).”
BackgroundThe blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“…in the human hippocampus, a region involved in learning and memory, but more accelerated degradation in patients with mild cognitive impairment (MCI) compared to age-matched neurologically intact controls, suggesting this phenomenon contributes to early cognitive impairment (Montagne et al., 2015).”
The blood–brain barrier in health and disease
Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 754
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Structure−Brain Exposure Relationships
Hitchcock, S. A., & Pennington, L. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060642i · Cited by 698
Metadata
- Authors
- Löscher, W., & Potschka, H.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 76
- Issue
- 1
- Pages
- 22-76
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2028441136
- Cited by
- 617
- References
- 380
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.